Introduction
The first developmental decision a hematopoietic stem cell makes is whether to differentiate into a common lymphoid progenitor or a common myeloid progenitor (1, 2) .
In general it is thought that there is normally infrequent cross-lineage differentiation once the stem cell differentiates into a lymphoid or myeloid progenitor (3) (4) (5) (6) (7) . Thus, a common lymphoid progenitor in normal situations is considered to rarely form myeloid lineages.
However, artificially enforcing myeloid gene expression in the murine common lymphoid progenitor can induce it to differentiate down myeloid lineages (3, 4) . For example, transducing the myeloid transcription factors C/EBP alpha or beta into B-cells re-programs them into macrophages in a PU.1-dependent manner.
However, enforcing myeloid gene expression is a circumstance not normally occurring in human hematopoiesis (3) . Recently, there have been two reports indicating that some normal human B-cell progenitors can rarely differentiate into macrophages or T/NK cells (8, 9) . While the frequency of this trans-lineage plasticity was rare, these studies called into question not only the lineage commitment of the differentiating stem cell but also the pathways available to the stem cell.
CXCR4 is the receptor for the chemokine CXCL12 (SDF-1, 10-12), and is required for hematopoietic stem cell engraftment and subsequent B-cell development (11) (12) (13) (14) (15) (16) (17) . It is almost universally expressed on hematopoietic progenitors, including B-cell progenitors and their more mature progeny (12, 13) . The CXCL12/CXCR4 axis not only regulates proper localization of B-cells progenitors, but also provides a proliferation and maturation signal to developing B-cells (14) (15) (16) (17) .
We sought to demonstrate whether relative expression of the B-cell chemokine receptor CXCR4 could define a distinct stage of B-cell progenitor development. We found that there was a subset of primitive B-cell progenitors that did not express CXCR4, but gained CXCR4 expression as they matured in lymphocyte culture. Significantly, these CXCR4-negative B-cell progenitors were flexible in their lymphoid lineage commitment, and could differentiate to multiple myeloid lineages at a significantly higher frequency than previously reported for any other B-cell progenitor type (8, 9) . These data imply a new, less restrictive pathway of hematopoietic stem cell differentiation. In brief, isolated bone marrow mononuclear cells were resuspended at 3 x 10 7 /ml in the final volume of 1ml of RPMI 1640 sterile medium supplemented with 10% fetal calf serum. The cells were incubated with 2 ug of the desired antibodies described above for 1 hour in the dark on ice. Cells were then washed in medium twice, and resuspended at 1 x 10 7 /ml in a 5ml polystyrene round bottom tube for sorting. A lymphocyte gate was established for both forward and side scatter, and sorting for desired fractions performed using stringent fluorescence gates to obtain pure fractions. All sorted cells were reanalyzed to ensure purity of the selected populations, and discarded if not 99% pure or better. All experiments were performed at least three times, using three distinct marrow samples, with the data averaged and standard errors indicated. Immunocytometry Systems, San Jose, CA). Low-density non-adherent bone marrow mononuclear cells were stained with the following antibodies: APC-conjugated antihuman CD34, PE-TR-conjugated anti-human CD19, and Biotin-conjugated anti-human CXCR4 (CD184). These cells were also stained with 3 of the following 6 antibodies: PECy5.5-conjugated anti-human CD90 or CD117, FITC-conjugated anti-human CD16 or CD33, and PE-conjugated anti-human CD127 or CD133. All antibodies were obtained from BD/Pharmingen (San Diego CA) except PE-TR-conjugated CD19 (Serotec, Raleigh NC), PE-conjugated CD127 (Beckman Coulter, Fullerton, CA), and PE-conjugated CD133 (Miltenyi Biotec, Auburn, CA). APC-Cy7-conjugated Streptavidin (BD/Pharmingen) was used as a secondary fluorochrome for Biotin conjugated anti-CXCR4. All flow cytometric analyses were performed at least three times using three distinct marrow samples, with the data averaged and standard deviations indicated.
Flow Analysis-

B-Cell Progenitor Culture-Sorted CD34
+ /CD19 + /CXCR4 -cells were cultured in 10%
PHA-stimulated human peripheral blood lymphocyte conditioned medium, SDF-1 (400 ng/ml), and IL-6 (10 ng/ml) then incubated at 37°C in a 5% CO 2 incubator as we described (22). All experiments were performed at least three times in triplicate with three distinct marrow samples, and the data averaged with standard errors indicated.
Colony Formation Assays-Burst Forming Unit-Erythroid (BFU-E), GranulocyteMacrophage (GM), and Granulocyte-Erythroid-Macrophage-Megakaryocyte (GEMM) colony formation assays were conducted as we previously reported (18,19). All experiments were performed at least three times in triplicate with three distinct marrow samples, and the results analyzed for differences using the Student's t-test. The most prominent antigen expressed on CD34 + /CD19 + /CXCR4 -cells was CD117.
CD117 (c-Kit) was expressed on an average of 16.0 +/-1.3% of these cells. CD16, CD33, CD90, CD127, and CD133 were all less well expressed than CD117. It should be noted that none of these markers were expressed on any appreciable fraction of these cells. defined here formed progenitors representing all myeloid lineages, which is in contrast to the more limited B-cell progenitor lineage plasticity described previously. It should also be noted that the progenitor defined here lacked the expression of IL-7Ralpha, and therefore may be a precursor of this previously described plastic B-cell progenitor type (8) . Therefore, the B-cell progenitor described here has greater lineage plasticity, able to truly function as a common myeloid progenitor besides giving rise to mature B-cells.
The paradigm of lymphoid development involves a committed decision by the stem cell to form a common lymphoid progenitor (1-4), which in turn differentiates into the B-and T-lineages. It is possible that this may not be completely applicable to all normal in vivo lymphoid development. The data here implies that the CXCR4 -B-cell progenitor may not have developed from a common progenitor committed to lymphoid lineages. This B-cell progenitor may be ontologically closer to a stem cell, and to the fundamental lymphoid-myeloid lineage decision, than a common lymphoid progenitor.
Two possible models explaining this finding are shown in Figure 4 . In Model A, the hematopoietic stem cell could form three common progenitors, the common myeloid progenitor (CMP), the common lymphoid progenitor (CLP), and the B-cell/myeloid common progenitor (BMP) described here. In Model B, the stem cell differentiates to only the CLP, which in turn differentiates to the BMP, and the CMP. While we favor Model A, as it is more consistent with murine data (1-7), one provocative possibility implied by this data is that the stem cell does not directly give rise to the common myeloid progenitor but has a single first differentiation step to a common lymphoid progenitor.
Another finding that also lends weight to this hypothesis is the phenotype of the PU.1 knock-out mouse (25,26). When PU.1 is homozygously deleted in a murine model, B-cells, macrophages, and granulocytes are missing, and the mice are anemic. While one explanation of this is that PU.1 is required in these distinct lineages at a similar primitive stage, perhaps a simpler explanation is that there is a common progenitor to these lineages that requires PU.1. This early hematopoietic progenitor in which PU.1 is required may be similar to the BMP defined here.
In addition, the Pax5 -/-B-cell progenitor can be induced to differentiate to macrophages simply by withdrawing lymphoid cytokines, indicating that Pax5 may be hematopoietic function in the CXCR4 -population (28). It is tempting to speculate that the BMP described here might be the engrafting cell in that report. While that report conflicts with previous studies which describe the expression of CXCR4 as essential for stem cell engraftment in immune deficient mice (17) , that report (28) is also more consistent with the data here.
The data presented here imply that the first developmental decision a stem cell makes, to differentiate down the lymphoid versus myeloid pathways, is not as final as was generally thought. Thus, while the common lymphoid progenitor certainly exists (1-
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